ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,000 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 2,803,645 | $84,782,000 | 78.57% |
| Cormorant Asset Management, LP | 400,000 | $12,096,000 | 2.49% |
| Deer VII & Co. Ltd. | 175,075 | $5,294,000 | 2.36% |
| QVT Financial LP | 1,193,258 | $36,084,000 | 1.86% |
| Foresite Capital Management I, LLC | 55,767 | $1,686,000 | 1.62% |
| Perceptive Advisors | 445,000 | $13,457,000 | 1.44% |
| SECTORAL ASSET MANAGEMENT INC | 726,424 | $21,967,000 | 0.92% |
| Iguana Healthcare Management, LLC | 25,000 | $756,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $3,024,000 | 0.37% |
| Eventide Asset Management | 62,100 | $1,878,000 | 0.26% |